Literature DB >> 23430167

[Acne therapy in pregnancy].

C Bayerl1.   

Abstract

Acne should be treated during pregnancy to prevent worsening, scarring, secondary infection or psychological impairment of the mother. Safe products must be chosen. Systemic tetracycline, doxycycline, minocycline or isotretinoin can not be used. Topical benzoyl peroxide or topical azelaic acid are safe therapeutic options. According to the guidelines, systemic corticosteroids or systemic erythromycin (the latter not in lactation) can be employed beginning in the second trimester for severe flares of acne and should be started in cooperation with the patient's gynecologist. Oral zinc is another option, but not for longer than 3 months. Accessory cosmetic measures may be useful, including mechanical peeling or chemical peeling with glycolic or alpha-hydroxy-acids. In contrast, salicylic acid, trichloracetic acid or phenol peels should not be performed in pregnancy. Camouflage makeup can clearly lower the psychological stress.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23430167     DOI: 10.1007/s00105-012-2456-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  25 in total

Review 1.  Dermatologic agents during pregnancy and lactation: an update and clinical review.

Authors:  Elizabeth K Hale; Miriam Keltz Pomeranz
Journal:  Int J Dermatol       Date:  2002-04       Impact factor: 2.736

Review 2.  [Adjuvant dermato-cosmetic acne therapy].

Authors:  Christiane Bayerl; Klaus Degitz; Eva Meigel; Martina Kerscher
Journal:  J Dtsch Dermatol Ges       Date:  2010-03       Impact factor: 5.584

Review 3.  Skin-lightening cosmetics: frequent, potentially severe adverse effects.

Authors: 
Journal:  Prescrire Int       Date:  2011-09

4.  Placental transfer of clindamycin and gentamicin in term pregnancy.

Authors:  A J Weinstein; R S Gibbs; M Gallagher
Journal:  Am J Obstet Gynecol       Date:  1976-04-01       Impact factor: 8.661

Review 5.  [Acne, pregnant women and zinc salts: a literature review].

Authors:  B Dréno; E Blouin
Journal:  Ann Dermatol Venereol       Date:  2008-01-18       Impact factor: 0.777

6.  The oral toxicity of resorcinol during pregnancy: a case report.

Authors:  Bulent Duran; Sinan Gursoy; Meral Cetin; Nihal Demirkoprulu; Yeltekin Demirel; Bilge Gurelik
Journal:  J Toxicol Clin Toxicol       Date:  2004

7.  Benzoyl peroxide: percutaneous penetration and metabolic disposition.

Authors:  S Nacht; D Yeung; J N Beasley; M D Anjo; H I Maibach
Journal:  J Am Acad Dermatol       Date:  1981-01       Impact factor: 11.527

8.  Systemic absorption of clindamycin hydrochloride after topical application.

Authors:  M Barza; J A Goldstein; A Kane; D S Feingold; P E Pochi
Journal:  J Am Acad Dermatol       Date:  1982-08       Impact factor: 11.527

9.  Pseudomembranous colitis after topical application of clindamycin.

Authors:  E B Milstone; A J McDonald; C F Scholhamer
Journal:  Arch Dermatol       Date:  1981-03

10.  Topical clindamycin therapy for acne vulgaris. A cooperative clinical study.

Authors:  L E Becker; P R Bergstresser; D A Whiting; W E Clendenning; R L Dobson; W P Jordan; E Abell; L A LeZotte; P E Pochi; J L Shupack; R B Sigafoes; R B Stoughton; J J Voorhees
Journal:  Arch Dermatol       Date:  1981-08
View more
  2 in total

Review 1.  [Acne and rosacea in pregnancy].

Authors:  S K Bechstein; F Ochsendorf
Journal:  Hautarzt       Date:  2017-02       Impact factor: 0.751

2.  Systemic exposure of topical erythromycin in comparison to oral administration and the effect on cytochrome P450 3A4 activity.

Authors:  Alexandra Carls; Julia Jedamzik; Lukas Witt; Nicolas Hohmann; Juergen Burhenne; Gerd Mikus
Journal:  Br J Clin Pharmacol       Date:  2014-12       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.